Cidara Therapeutics, Inc. (CDTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 170.68M |
| Enterprise Value | -15.57M |
| P/E Ratio | -34.54 |
| PEG Ratio | -1.17 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 8.15 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -40.22 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.26 |
| Return On Equity | -0.37 |
Income Statement
| Revenue | 1.27M |
| Revenue/Share | 0 |
| Gross Profit | 1.27M |
| EBITDA | -170.06M |
| Net Income | -169.83M |
| Diluted EPS | -26.75 |
Balance Sheet
| Total Cash | 293.65M |
| Total Cash/Share | 18.89 |
| Total Debt | 1.98M |
| Total Debt/Equity | 0 |
| Current Ratio | 4.62 |
| Book Value Per Share | 27.17 |
Price History
| 52-Week Change | 921.13 |
| 52-Week High | 221.42 |
| 52-Week Low | 15.22 |
| Moving Average 50 Days | 187.66 |
| Moving Average 200 Days | 84.67 |
Statistics
| Average Volume | 1.37M |
| Shares Outstanding | 25.36M |
| % Held by Institutions | 214.23 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | April 24, 2024 |
AD
